278 related articles for article (PubMed ID: 3042255)
1. Proinsulin, insulin, and C-peptide in cystic fibrosis after an oral glucose tolerance test.
Hartling SG; Garne S; Binder C; Heilmann C; Petersen W; Petersen KE; Koch C
Diabetes Res; 1988 Apr; 7(4):165-9. PubMed ID: 3042255
[TBL] [Abstract][Full Text] [Related]
2. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
[TBL] [Abstract][Full Text] [Related]
3. Insulin and C-peptide responses to glucose load in cystic fibrosis.
Mohan V; Alagappan V; Snehalatha C; Ramachandran A; Thiruvengadam KV; Viswanathan M
Diabete Metab; 1985 Dec; 11(6):376-9. PubMed ID: 3910489
[TBL] [Abstract][Full Text] [Related]
4. [Glucose homeostasis in cystic fibrosis. Oral glucose tolerance test in comparison with formula administration].
Skopnik H; Kentrup H; Kusenbach G; Pfäffle R; Kock R
Monatsschr Kinderheilkd; 1993 Jan; 141(1):42-7. PubMed ID: 8446117
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients.
Holl RW; Wolf A; Thon A; Bernhard M; Buck C; Missel M; Heinze E; von der Hardt H; Teller WM
J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):188-93. PubMed ID: 9252906
[TBL] [Abstract][Full Text] [Related]
6. Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance.
Moreau F; Weiller MA; Rosner V; Weiss L; Hasselmann M; Pinget M; Kessler R; Kessler L
Horm Metab Res; 2008 Jul; 40(7):502-6. PubMed ID: 18415892
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of dysfunction of islet beta-cell in newly diagnosed type 2 diabetic patients].
Li YB; Zhu DL; Tian HM; Shi LX; Luo ZJ; Yan L; Zeng LY; Zhou ZG; Yang LY; Liu J; Li M; Weng JP
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(36):2537-41. PubMed ID: 17198561
[TBL] [Abstract][Full Text] [Related]
8. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
9. Increased blood proinsulin and decreased C-peptide levels in patients with pancreatic cancer.
Nakamori S; Ishikawa O; Ohigashi H; Sasakuma F; Shimizu T; Nakaizumi A; Furukawa H; Sasaki Y; Imaoka S
Hepatogastroenterology; 1999; 46(25):16-24. PubMed ID: 10228759
[TBL] [Abstract][Full Text] [Related]
10. Plasma insulin, C-peptide, and proinsulin concentrations in obese and nonobese individuals with varying degrees of glucose tolerance.
Reaven GM; Chen YD; Hollenbeck CB; Sheu WH; Ostrega D; Polonsky KS
J Clin Endocrinol Metab; 1993 Jan; 76(1):44-8. PubMed ID: 8421101
[TBL] [Abstract][Full Text] [Related]
11. Proinsulin, proinsulin intermediate and insulin in cystic fibrosis.
Hamdi I; Green M; Shneerson JM; Palmer CR; Hales CN
Clin Endocrinol (Oxf); 1993 Jul; 39(1):21-6. PubMed ID: 8348704
[TBL] [Abstract][Full Text] [Related]
12. The effect of age on plasma proinsulin-like material after oral glucose.
Duckworth WC; Kitabchi AE
J Lab Clin Med; 1976 Sep; 88(3):359-67. PubMed ID: 956690
[TBL] [Abstract][Full Text] [Related]
13. Carbohydrate tolerance in cystic fibrosis is closely linked to pancreatic exocrine function.
Geffner ME; Lippe BM; Kaplan SA; Itami RM; Gillard BK; Levin SR; Taylor IL
Pediatr Res; 1984 Nov; 18(11):1107-11. PubMed ID: 6083538
[TBL] [Abstract][Full Text] [Related]
14. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
[TBL] [Abstract][Full Text] [Related]
15. Familial hyperproinsulinemia due to a proposed defect in conversion of proinsulin to insulin.
Gruppuso PA; Gorden P; Kahn CR; Cornblath M; Zeller WP; Schwartz R
N Engl J Med; 1984 Sep; 311(10):629-34. PubMed ID: 6382002
[TBL] [Abstract][Full Text] [Related]
16. Patients with cystic fibrosis and normoglycemia exhibit diabetic glucose tolerance during pulmonary exacerbation.
Sc NN; Shoseyov D; Kerem E; Zangen DH
J Cyst Fibros; 2010 May; 9(3):199-204. PubMed ID: 20188638
[TBL] [Abstract][Full Text] [Related]
17. Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.
Sheikh S; Gudipaty L; De Leon DD; Hadjiliadis D; Kubrak C; Rosenfeld NK; Nyirjesy SC; Peleckis AJ; Malik S; Stefanovski D; Cuchel M; Rubenstein RC; Kelly A; Rickels MR
Diabetes; 2017 Jan; 66(1):134-144. PubMed ID: 27495225
[TBL] [Abstract][Full Text] [Related]
18. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
Kilberg MJ; Harris C; Sheikh S; Stefanovski D; Cuchel M; Kubrak C; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
J Clin Endocrinol Metab; 2020 Oct; 105(10):3179-89. PubMed ID: 32668452
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of women with previous GDM. Insulin, C-peptide, and proinsulin responses to oral glucose load.
Persson B; Hanson U; Hartling SG; Binder C
Diabetes; 1991 Dec; 40 Suppl 2():136-41. PubMed ID: 1748243
[TBL] [Abstract][Full Text] [Related]
20. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
